Search results
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
United Press International via Yahoo News· 5 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Medical Xpress· 6 days agoA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers...
CAR T cell therapy for advanced prostate cancer demonstrates positive results in Phase I clinical...
Medical Xpress· 6 days agoThe trial treated 14 prostate stem cell antigen (PSCA)-positive patients who had metastatic castration resistant prostate cancer (mCRPC), which had spread beyond the prostate and no longer responded ...
Boosting CAR-T cell therapies from under the skin
Medical Xpress· 6 days agoOncological researchers suspect that disappointing treatment results can be the result of several circumstances, including poor quality of the CAR-T < ...
Why Is Mustang Bio (MBIO) Stock Up 347% Today?
InvestorPlace· 1 day agoThe recent news includes favorable results from the company’s Phase 1/2 clinical trial of MB-106. This is a CD20-targeted, autologous CAR T-cell ...
New blood cancer treatment saving lives, UVM officials say
WCAX-TV Vermont· 3 hours agoUniversity of Vermont Cancer Center officials say a promising treatment for blood cancer launched...
Train Eyes so Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke
MedPage Today· 4 days agoTTHealthWatch is a weekly podcast from Texas Tech. This week's topics include eye training to...
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
MedPage Today· 7 days agoOnly one of 724 patients treated with chimeric antigen receptor (CAR) T-cell therapy for B-cell...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 5 days agoNew research provides insight into ultra-rare case of secondary cancer in a patient who received CAR...
CARsgen’s CAR T MM therapy shows early signs of efficacy in Phase I trial
Clinical Trials Arena via Yahoo Finance· 1 day agoT cell immunotherapies. The agency said it had determined that the risk of T-cell malignancies was...